| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | 124,0 k € | -31.9% | 182,2 k € | -6.7% | 195,2 k € | +3.6% | 188,5 k € | +59.5% | 118,2 k € | |||||||||||||
| Gross margin | 118,7 k € | +19.9% | 99,0 k € | -1.6% | 100,6 k € | +7.5% | 93,6 k € | +8.7% | 86,1 k € | +6.9% | 80,5 k € | -12.9% | 92,5 k € | +15.2% | 80,3 k € | -6.4% | 85,7 k € | +10.8% | 77,4 k € | +26.0% | 61,4 k € | -29.2% | 86,8 k € | +11.4% | 77,9 k € | -5.8% | 82,7 k € | -6.7% | 88,6 k € | +17.5% | 75,4 k € | -6.3% | 80,4 k € | |
| EBITDA | 100,6 k € | +50.7% | 66,7 k € | +7.6% | 62,1 k € | +6.1% | 58,5 k € | +7.5% | 54,4 k € | +77.0% | 30,7 k € | -42.6% | 53,5 k € | +17.8% | 45,4 k € | -14.6% | 53,2 k € | +18.5% | 44,9 k € | +35.4% | 33,1 k € | -48.5% | 64,4 k € | +10.9% | 58,1 k € | -9.6% | 64,2 k € | -8.0% | 69,7 k € | +22.6% | 56,9 k € | -13.2% | 65,5 k € | |
| Operating profit | 65,7 k € | +101.6% | 32,6 k € | +27.3% | 25,6 k € | +43.2% | 17,9 k € | +21.2% | 14,8 k € | +337.7% | -6,2 k € | -135.4% | 17,5 k € | +74.4% | 10,0 k € | -46.9% | 18,9 k € | +76.4% | 10,7 k € | +4735.6% | -231,5 € | -100.6% | 35,8 k € | +5.1% | 34,1 k € | -12.0% | 38,7 k € | -13.8% | 44,9 k € | +21.4% | 37,0 k € | -22.1% | 47,5 k € | |
| Profit/loss | 45,1 k € | +98.2% | 22,8 k € | +33.3% | 17,1 k € | +63.2% | 10,5 k € | +9.5% | 9,6 k € | +200.1% | -9,5 k € | -226.7% | 7,5 k € | +239.8% | 2,2 k € | -41.1% | 3,8 k € | +26.9% | 3,0 k € | +137.5% | -7,9 k € | -136.0% | 22,0 k € | +0.1% | 22,0 k € | -8.0% | 23,9 k € | +0.3% | 23,8 k € | +2.0% | 23,4 k € | -20.6% | 29,4 k € | |
| Equity | 326,5 k € | +16.0% | 281,4 k € | +4.6% | 269,0 k € | +3.7% | 259,5 k € | +3.3% | 251,2 k € | +2.4% | 245,4 k € | +0.3% | 244,6 k € | +3.2% | 237,1 k € | +0.9% | 234,8 k € | +1.6% | 231,1 k € | +1.3% | 228,1 k € | -3.4% | 236,0 k € | +9.1% | 216,4 k € | +11.3% | 194,4 k € | +12.4% | 172,9 k € | +14.1% | 151,5 k € | +16.0% | 130,6 k € | |
| Total assets | 341,1 k € | +1.4% | 336,3 k € | +0.3% | 335,3 k € | -3.1% | 346,0 k € | -8.7% | 379,1 k € | +16.5% | 325,4 k € | -11.4% | 367,3 k € | -2.4% | 376,3 k € | -6.1% | 400,6 k € | -4.8% | 420,8 k € | -5.5% | 445,2 k € | -3.8% | 462,7 k € | +7.5% | 430,6 k € | +9.2% | 394,5 k € | -4.0% | 411,1 k € | +76.5% | 233,0 k € | -2.1% | 237,9 k € | |
| Cash | 81,7 k € | +203.3% | 27,0 k € | -12.1% | 30,7 k € | +5.0% | 29,2 k € | -66.3% | 86,8 k € | +226.5% | 26,6 k € | -30.4% | 38,2 k € | +101.8% | 18,9 k € | -24.0% | 24,9 k € | +865.1% | 2,6 k € | -52.5% | 5,4 k € | -86.1% | 39,1 k € | +30.1% | 30,0 k € | +36.6% | 22,0 k € | +22.1% | 18,0 k € | +152.0% | 7,1 k € | -15.3% | 8,4 k € | |
| Debts | 14,6 k € | -73.5% | 54,9 k € | -17.3% | 66,3 k € | -23.4% | 86,6 k € | -32.0% | 127,3 k € | +60.5% | 79,4 k € | -35.3% | 122,7 k € | -11.9% | 139,2 k € | -15.6% | 164,9 k € | -12.4% | 188,2 k € | -13.3% | 217,1 k € | -4.2% | 226,6 k € | +6.7% | 212,5 k € | +6.2% | 200,1 k € | -16.0% | 238,2 k € | +192.4% | 81,4 k € | -24.1% | 107,3 k € | |
| Staff | — | — | — | — | — | — | — | — | — | 0,9 | 0,9 | 0,5 | 0,5 | 0,5 | 0,1 | 0,6 | 0,6 | |||||||||||||||||
Private limited company · Sint-Pieters-Leeuw · incorporated on 16/04/1992
Private limited company profitable and well capitalised. Cash position rising (+203.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR. STEGEN PETER,HUISARTSGENEESKUNDE is a Private limited company incorporated in 1992. Its main activity is: Pre-primary education. Its registered office is in Sint-Pieters-Leeuw.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette